M. Albitar

Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors

Background Cerebrospinal fluid (CSF) is a relatively accessible biospecimen, and liquid biopsy (LBx) testing using next-generation sequencing (NGS) provides actionable information on genomic abnormalities that can guide clinical decisions and therapeutic selection. To evaluate the potential clinical utility of CSF LBx,...